The effect of particular active substances of hallucinogenic mushrooms

Marek Wieczorek

doi:10.2478/fobio-2014-0014

Authors

Marek Wieczorek University of Lodz, Faculty of Biology and Environmental Protection, Department of Neurobiology, Lodz, Poland

DOI:

https://doi.org/10.2478/fobio-2014-0014

Keywords:

magic mushrooms, psilocin, psilocybin, ibotenic acid, muscimol

Abstract

Magic mushrooms have accompanied man for thousands of years. Formerly they were used for religious and culture purposes. Those fungi belong mainly to the genera Conocybe, Copelandia, Panaeolus, Psilocybe and Stropharia. A number of these fungal species produce substances, like psilocybin, psilocin, ibotenic acid or muscimol. Because of their chemical similarity to naturally occurring neurotransmitters like serotonin and GABA these substances, after ingestion, affect brain neurochemistry and by this induce hallucinations. This mini review presents the influence of psilocybin, psilocin, ibotenic acid and muscimol on the nervous system. Also the effects of the above mentioned substances on emotion and mental health of people are discussed.

Downloads

Download data is not yet available.

References

Aghajanian, G.K. & Marek, G.J. 1999. Serotonin and hallucinogens. Neuropsychopharmacology, 21: 16S–23S.

Carter, O.L., Pettigrew, J.D., Hasler, F., Wallis, G.M., Liu, G.B., Hell, D. & Vollenweider, F.X. 2005. Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin. Neuropsychopharmacology, 30: 1154–1162.

Delgado, P.L. & Moreno, F.A. 1998. Hallucinogens, serotonin and obsessive-compulsive disorder. J Psychoactive Drugs, 30: 359–366.

Gonzalez-Maeso, J. & Sealfon, S.C. 2009. Psychedelics and schizophrenia. Trends Neurosci, 32: 225–232.

Halpern, J.H. 2004. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther, 102: 131–138.

Hopf, A. & Eckert, H. 1974. Distribution patterns of 14-C-psilocin in the brains of various animals. Act Nerv Super (Praha), 16: 64–66.

Hyde, C., Glancy, G., Omerod, P., Hall, D. & Taylor, G.S. 1978. Abuse of indigenous psilocybin mushrooms: a new fashion and some psychiatric complications. Br J Psychiatry, 132: 602–604.

Ikeda, A., Sekiguchi, K., Fujita, K., Yamadera, H. & Koga, Y. 2005. 5-methoxy-N,N-diisopropyltryptamine-induced flashbacks. Am J Psychiatry, 162: 815.

McDonald, A. 1980. Mushrooms and madness. Hallucinogenic mushrooms and some psychopharmacological implications. Can J Psychiatry. 25: 586–594.

Meyer, J.S. & Quenzer, L.F. 2005. Psychopharmacology. Drugs, the Brain, and Behavior. Sinauer Associates, Inc. Sunderland, Massachusetts, USA.

Muller, K., Puschel, K. & Iwersen-Bergmann, S. 2013. Suicide under the influence of "magic mushrooms". Arch Kriminol, 231: 193–198.

Passie, T., Seifert, J., Schneider, U. & Emrich, H.M., 2002. The pharmacology of psilocybin. Addict Biol, 7, 357–364.

Satora, L., Goszcz, H. & Ciszowski, K. 2005. Poisonings resulting from the ingestion of magic mushrooms in Krakow. Przegl Lek, 62, 394–396.

Stebelska, K. 2013. Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities. Ther Drug Monit, 35: 420–442.

Tsujikawa, K., Mohri, H., Kuwayama, K., Miyaguchi, H., Iwata, Y., Gohda, A., Fukushima, S., Inoue, H. & Kishi, T. 2006. Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Sci Int. 164: 172–178.